Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cushman & Wakefield (CWK) EBT (2017 - 2026)

Cushman & Wakefield has reported EBT over the past 9 years, most recently at -$43.3 million for Q4 2025.

  • For Q4 2025, EBT fell 132.78% year-over-year to -$43.3 million; the TTM value through Dec 2025 reached $83.0 million, down 52.79%, while the annual FY2025 figure was $114.2 million, 35.04% down from the prior year.
  • EBT for Q4 2025 was -$43.3 million at Cushman & Wakefield, down from $45.1 million in the prior quarter.
  • Over five years, EBT peaked at $197.6 million in Q4 2021 and troughed at -$89.2 million in Q1 2023.
  • A 5-year average of $45.3 million and a median of $51.6 million in 2022 define the central range for EBT.
  • Biggest five-year swings in EBT: crashed 217.21% in 2023 and later soared 406.36% in 2024.
  • Year by year, EBT stood at $197.6 million in 2021, then tumbled by 55.06% to $88.8 million in 2022, then fell by 21.06% to $70.1 million in 2023, then soared by 88.45% to $132.1 million in 2024, then plummeted by 132.78% to -$43.3 million in 2025.
  • Business Quant data shows EBT for CWK at -$43.3 million in Q4 2025, $45.1 million in Q3 2025, and $76.2 million in Q2 2025.